Clinical Trial Update: Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated a mitochondrial-targeted antioxidant in patients with Peripheral Artery Disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Mitochondria-targeted antioxidant

Snippet

Sponsor: University of Nebraska | Conditions: Peripheral Arterial Disease, Peripheral Artery Disease | NA | Status: COMPLETED | Results posted: 2024-11-12